Cognoa is an early childhood development and pediatric behavioral health company that focuses on developing digital diagnostics and therapeutics. With a mission to enable earlier and more equitable access to care, Cognoa aims to improve the lives and outcomes of children and families. Their flagship product, Canvas Dx, is the first and only FDA authorized diagnostic solution designed to diagnose or rule out autism in children ages 1. 5 to 6 years. By using intelligent technology, Cognoa is able to provide a remote, digital evaluation that is rapid and equitable, helping to eliminate delays and biases in the diagnosis of developmental conditions.